Benefits
Blood pressure compared with placebo
In 28 adults with metabolic syndrome, 150 mg a day of a standardized celery seed extract for 12 weeks lowered systolic pressure by about 5 mmHg while it rose about 3 mmHg on placebo (p = 0.001), with a smaller diastolic difference. A 4-week crossover in 52 people with high blood pressure saw readings fall in the celery phase, compared only with each phase's own baseline. Both trials were small.
Serum uric acid in a 12-week placebo-controlled trial
In the same 28-person trial, serum uric acid fell by about 35 micromol/L on the celery seed extract and rose by about 14 on placebo, a significant difference between groups (p = 0.001). It is the only human trial found that measured uric acid. No trial has measured gout flares, joint pain or joint comfort, so those uses remain untested in people.
Sexual function scores in women
In a double-blind trial, 80 women with sexual dysfunction took 500 mg of celery seed or placebo three times a day for 6 weeks. The total Female Sexual Function Index rose more with celery seed than with placebo (p < 0.001), driven by the desire, arousal, lubrication and pain domains. No serious side effects were seen. It is a single trial from one center.
Triglycerides, cholesterol and fasting glucose
Results on blood fats and sugar are less clear. In the 12-week placebo-controlled trial, triglycerides fell within the celery group, but the difference from placebo missed significance (p = 0.066), and cholesterol, fasting glucose and insulin sensitivity did not change. A 4-week crossover reported lower cholesterol, triglycerides and fasting glucose during the celery phase, compared only with each phase's own baseline.
Uric acid and joint swelling in rodent studies (animal work)
In mice with drug-induced high uric acid, oral water and oil extracts of celery seed lowered serum uric acid and xanthine oxidase, the enzyme that makes uric acid. In rats with urate crystals injected into the ankle, the extracts reduced joint swelling and inflammatory markers. These are animal results and have not been shown in people.
Mechanism of action
Phthalides in the seed oil
Celery seed oil is mostly limonene (about 42 percent) and beta-selinene (about 17 percent), but phthalides make up roughly a quarter of it. In seven batches analyzed for an EU safety opinion, senkyunolide A averaged about 14 percent and 3-n-butylphthalide about 10 percent (range 3.3 to 15.2 percent). Extracts sold for 3nB content are standardized to this phthalide fraction.
Xanthine oxidase and uric acid in animals
In hyperuricemic mice, oral celery seed water and oil extracts lowered both serum uric acid and serum xanthine oxidase, and raised the antioxidant enzymes superoxide dismutase and glutathione peroxidase. This points to reduced uric acid production as a possible pathway, but it has only been shown in rodents.
Proposed vascular relaxation by 3nB and apigenin
Trial authors attribute the blood pressure changes to 3-n-butylphthalide and apigenin, which they describe as having calcium channel blocking and nitric oxide related vasodilating effects. This mechanism was not measured in any of the human trials, so it remains a proposed explanation.
Clinical trials
Randomized, double-blind, placebo-controlled trial (NCT06061926) of a commercial celery seed extract (Natural Factors) declared as standardized to 85% 3-n-butylphthalide, not the Celery3nB brand (75 mg twice daily) versus placebo for 12 weeks; no external funding. (Escobedo-Gutiérrez et al. 2026, Pharmaceuticals (Basel))
28 adults with metabolic syndrome in Guadalajara, Mexico (14 per group), mean age about 47.
Compared with placebo, systolic pressure fell (minus 5.43 vs plus 3.14 mmHg, p = 0.001), diastolic pressure fell (minus 3.72 vs plus 0.57 mmHg, p = 0.011) and uric acid fell (minus 34.56 vs plus 14.45 micromol/L, p = 0.001). Triglycerides and VLDL dropped within the celery group but not significantly versus placebo (p = 0.066). Glucose, cholesterol, body weight, insulin sensitivity and insulin secretion did not differ. Side effects were mild and similar between groups.
Parallel, randomized, double-blind, placebo-controlled trial of 500 mg celery seed (Apium graveolens fruit) three times a day for 6 weeks, scored with the Female Sexual Function Index. (Hessami et al. 2021, J Ethnopharmacol)
80 women with sexual dysfunction in Shiraz, Iran (40 per group).
At 6 weeks the total FSFI score improved significantly more with celery seed than with placebo (p < 0.001), mainly through the desire, arousal and lubrication domains (each p < 0.001) and the pain domain (p = 0.033). No serious side effects were noticed in either group. A single, short trial from one university.
Randomized, triple-blind, placebo-controlled crossover trial of four celery seed extract capsules a day (1.34 g in total) for 4 weeks, added to usual blood pressure medication, with 24-hour ambulatory monitoring. The same Mashhad team published blood pressure, lab safety and mood results in three reports with the same design and dose, which appear to describe one trial (registered as IRCT20130418013058N8 in the mood report). (Shayani Rad et al. 2022, Phytother Res)
50 to 52 patients with high blood pressure in Mashhad, Iran, who completed both phases.
During the celery phase, 24-hour systolic pressure fell from 141.2 to 130.0 mmHg and diastolic from 92.2 to 84.2 mmHg (both p < .001), with no significant change in the placebo phase. Companion reports described lower fasting glucose, blood fats and Beck anxiety and depression scores during the celery phase. All results are changes within each phase; the abstracts give no direct comparison between phases. Side effects did not differ from placebo, and the extract brand is not named.
Rodent study of a celery seed water extract and a celery seed oil extract given by gavage, compared with untreated models and with febuxostat or colchicine. (Li et al. 2019, Mol Med Rep)
Mice with uric acid raised by potassium oxonate and yeast extract; rats with urate crystals injected into the ankle joint (12 animals per group).
Both extracts lowered serum uric acid and xanthine oxidase in the mice and raised antioxidant enzymes. In the rats they reduced ankle swelling, inflammatory cell infiltration, IL-1 beta and TNF alpha. These are animal models and do not show an effect on uric acid or gout in people.
Good Laboratory Practice 28-day study of an alcoholic celery seed extract given by mouth at 0, 150 or 5,000 mg/kg a day. (Powanda et al. 2011, Inflammopharmacology)
36 adult rats (6 per sex per dose group).
All animals survived with no visible signs of toxicity and no differences in weight gain. High-dose rats had slightly heavier livers without microscopic changes, and small shifts in some blood and urine values were judged not toxicologically significant. The authors put the no adverse effect level at 5,000 mg/kg a day. Rat data cannot set a safe human dose.